Peptide Associates

Sarasota, Florida – 27 May 2026 – Peptide Associates today announced the rollout of its new simplified access model for GLP-3/Triple G injection-based wellness support, reinforcing the company’s commitment to making professionally guided peptide wellness programs more approachable, community-focused, and operationally streamlined for today’s consumers. The newly introduced model is designed to improve how individuals […] Continue Reading →

Sarasota, Florida – 25 May 2026 – Peptide Associates today announced the expansion of its peptide wellness portfolio through the introduction of its GLP-3/Triple G Injection Offering, a new initiative designed to support the evolving needs of modern wellness consumers seeking structured metabolic support and professionally guided wellness solutions. The announcement marks another milestone in […] Continue Reading →